Updated data for phase I/II study of BMS-986205 plus nivolumab in advanced bladder cancer July 4, 2018
ARCHER 1050 study demonstrates superiority of dacomitinib to gefitinib in advanced NSCLC July 4, 2018
Phase II results presented for osimertinib in NSCLC harboring uncommon EGFR gene mutations July 4, 2018
Brain infusion of recombinant poliovirus therapy prolongs survival in recurrent glioblastoma July 4, 2018
RSS